HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.

Abstract
Neurologic disorders, mainly Guillain-Barré syndrome and Parsonage–Turner syndrome (PTS), have been described in patients with hepatitis E virus (HEV) infection in industrialized and developing countries. We report a wider range of neurologic disorders in nonimmunocompromised patients with acute HEV infection. Data from 15 French immunocompetent patients with acute HEV infection and neurologic disorders were retrospectively recorded from January 2006 through June 2013. The disorders could be divided into 4 main entities: mononeuritis multiplex, PTS, meningoradiculitis, and acute demyelinating neuropathy. HEV infection was treated with ribavirin in 3 patients (for PTS or mononeuritis multiplex). One patient was treated with corticosteroids (for mononeuropathy multiplex), and 5 others received intravenous immunoglobulin (for PTS, meningoradiculitis, Guillain-Barré syndrome, or Miller Fisher syndrome). We conclude that pleiotropic neurologic disorders are seen in HEV-infected immunocompetent patients. Patients with acute neurologic manifestations and aminotransferase abnormalities should be screened for HEV infection.
AuthorsH Blasco Perrin, P Cintas, F Abravanel, R Gérolami, L d'Alteroche, J-N Raynal, L Alric, E Dupuis, L Prudhomme, E Vaucher, P Couzigou, J-M Liversain, C Bureau, J-P Vinel, N Kamar, J Izopet, J-M Peron
JournalEmerging infectious diseases (Emerg Infect Dis) Vol. 21 Issue 11 Pg. 1928-34 (Nov 2015) ISSN: 1080-6059 [Electronic] United States
PMID26490255 (Publication Type: Journal Article)
Topics
  • Acute Disease (mortality)
  • Adult
  • Aged
  • Education, Medical, Continuing
  • Female
  • Hepatitis E (complications, physiopathology)
  • Humans
  • Immunocompetence
  • Male
  • Middle Aged
  • Nervous System Diseases (etiology, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: